Free Trial
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free PGEN Stock Alerts

Precigen (PGEN) Financials

Precigen logo
$4.42 -0.18 (-3.91%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$4.39 -0.03 (-0.68%)
As of 05/15/2026 07:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Precigen

Annual Income Statements for Precigen

This table shows Precigen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -82 -84 -187 -685 -171 -92 28 -96 -126 -430
Consolidated Net Income / (Loss)		 -86 -88 -190 -646 -64 -92 35 -96 -126 -251
Net Income / (Loss) Continuing Operations		 -86 -88 -190 -170 2.56 -111 -80 -96 -126 -251
Total Pre-Tax Income 		-86 -87 -194 -343 2.48 -111 -80 -96 -128 -251
Total Operating Income		 -70 -147 -125 -167 3.66 -92 -76 -100 -135 -111
Total Gross Profit		 53 110 129 -61 27 8.52 21 0.11 -0.34 4.86
Total Revenue		 72 174 191 0.00 32 14 27 6.23 3.93 9.68
Operating Revenue		 71 173 191 - 32 14 27 6.23 3.93 9.68
Total Cost of Revenue		 19 64 62 61 5.37 5.75 6.34 6.12 4.27 4.82
Operating Cost of Revenue		 19 64 62 61 5.37 5.75 6.34 6.12 4.27 4.82
Total Operating Expenses		 123 257 254 317 23 101 96 100 135 115
Selling, General & Admin Expense		 64 109 142 99 0.00 52 48 40 41 70
Research & Development Expense		 59 147 112 67 0.00 48 47 49 53 41
Impairment Charge		 - 0.00 0.00 151 23 0.54 1.12 11 40 3.91
Total Other Income / (Expense), net		 -16 60 -69 -3.37 -1.18 -19 2.53 3.40 7.00 -140
Interest Expense		 0.67 1.24 0.86 18 0.00 19 - 0.47 0.01 3.87
Interest & Investment Income		 -15 60 -70 11 -1.18 0.17 1.00 3.24 1.42 3.22
Other Income / (Expense), net		 -0.17 1.31 1.70 3.45 0.00 -0.43 1.54 0.63 5.59 -139
Income Tax Expense		 -0.10 1.02 -3.88 -1.86 -0.08 -0.32 -0.19 -0.46 -1.79 0.00
Preferred Stock Dividends Declared		 - - - - - - - 0.00 0.00 179
Basic Earnings per Share		 ($0.83) ($0.76) ($1.58) ($2.09) - ($0.47) $0.14 ($0.39) ($0.47) ($1.37)
Weighted Average Basic Shares Outstanding		 99.17M 111.07M 117.98M 154.14M 167.07M 197.76M 200.36M 244.54M 267.73M 312.98M
Diluted Earnings per Share		 ($0.83) ($0.76) ($1.58) ($2.09) - ($0.47) $0.14 ($0.39) ($0.47) ($1.37)
Weighted Average Diluted Shares Outstanding		 99.17M 111.07M 117.98M 154.14M 167.07M 197.76M 200.36M 244.54M 267.73M 312.98M
Weighted Average Basic & Diluted Shares Outstanding		 99.17M 111.07M 117.98M 154.14M 167.07M 206.93M 252.19M 248.92M 294.04M 353.93M

Quarterly Income Statements for Precigen

This table shows Precigen's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -20 -33 -24 -58 -24 -21 -54 -26 -325 -26 -7.93
Consolidated Net Income / (Loss)		 -20 -33 -24 -59 -24 -20 -54 -27 -146 -24 -7.93
Net Income / (Loss) Continuing Operations		 -20 -34 -24 -58 -24 -21 -54 -26 -146 -26 -7.93
Total Pre-Tax Income 		-20 -33 0.00 -60 -24 -20 -54 -27 -146 -24 -7.93
Total Operating Income		 -21 -34 -24 -61 -21 -29 -23 -32 -34 -22 -5.99
Total Gross Profit		 -0.16 -0.13 -0.01 0.42 -0.06 -4.62 0.24 0.62 1.89 0.77 21
Total Revenue		 1.38 1.23 1.07 1.43 0.95 -3.45 1.34 1.71 2.92 2.37 23
Operating Revenue		 1.38 1.23 1.07 1.43 0.95 - 1.34 1.71 2.92 2.37 23
Total Cost of Revenue		 1.54 1.36 1.08 1.01 1.01 1.17 1.10 1.09 1.04 1.60 2.56
Operating Cost of Revenue		 1.54 1.36 1.08 1.01 1.01 1.17 1.10 1.09 1.04 1.60 2.56
Total Operating Expenses		 21 34 24 61 21 34 23 32 36 25 27
Selling, General & Admin Expense		 9.20 10 10 10 9.84 11 12 16 24 18 21
Research & Development Expense		 12 13 14 16 11 12 10 11 12 6.99 5.64
Total Other Income / (Expense), net		 1.14 1.17 0.64 0.36 -2.70 8.70 -32 5.13 -112 -1.84 -1.94
Interest Expense		 - - - 0.00 - - 0.00 0.00 - - 2.91
Interest & Investment Income		 0.86 0.92 0.61 0.32 0.28 0.21 0.92 0.70 0.53 1.07 0.68
Other Income / (Expense), net		 0.28 -0.08 0.04 0.04 -2.99 17 -32 4.43 -111 0.06 0.29
Income Tax Expense		 -0.01 - -0.06 -1.69 0.02 -0.16 0.00 0.00 0.00 - 0.00
Basic Earnings per Share		 ($0.08) ($0.13) ($0.10) ($0.23) ($0.09) ($0.05) ($0.18) ($0.09) ($1.06) ($0.04) ($0.02)
Weighted Average Basic Shares Outstanding		 248.52M 244.54M 249.22M 252.37M 275.88M 267.73M 293.88M 296.43M 307.17M 312.98M 354.29M
Diluted Earnings per Share		 ($0.08) ($0.13) ($0.10) ($0.23) ($0.09) ($0.05) ($0.18) ($0.09) ($1.06) ($0.04) ($0.02)
Weighted Average Diluted Shares Outstanding		 248.52M 244.54M 249.22M 252.37M 275.88M 267.73M 293.88M 296.43M 307.17M 312.98M 354.29M
Weighted Average Basic & Diluted Shares Outstanding		 248.92M 248.92M 252.42M 252.76M 292.87M 294.04M 295.18M 297.97M 353.82M 353.93M 356.51M

Annual Cash Flow Statements for Precigen

This table details how cash moves in and out of Precigen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 108 -66 4.90 34 -42 -16 -8.91 5.25 -41 22 0.72
Net Cash From Operating Activities		 36 -49 -104 -124 -136 -77 -56 -65 -67 -68 -88
Net Cash From Continuing Operating Activities		 36 -49 -104 -124 -136 -77 -56 -65 -67 -68 -88
Net Income / (Loss) Continuing Operations		 -88 -190 -127 -515 -324 -171 -92 28 -96 -126 -251
Consolidated Net Income / (Loss)		 -88 -190 -127 -515 -324 -171 -92 28 -96 -126 -251
Depreciation Expense		 -49 83 34 63 25 18 14 11 6.67 4.53 3.20
Amortization Expense		 0.64 1.07 -0.41 3.61 8.45 9.89 13 1.87 -1.75 -0.88 -1.85
Non-Cash Adjustments To Reconcile Net Income		 112 71 71 365 156 87 11 -70 7.46 52 154
Changes in Operating Assets and Liabilities, net		 60 -14 -81 -41 -1.25 -21 -0.97 -36 17 2.73 7.36
Net Cash From Investing Activities		 -259 -28 104 -151 87 28 -75 226 -3.09 -21 -1.54
Net Cash From Continuing Investing Activities		 -259 -28 104 -151 87 28 -75 226 -3.09 -21 -1.54
Purchase of Property, Plant & Equipment		 -13 -32 -47 -42 -38 -7.53 -7.25 -4.92 -1.54 -8.58 -2.00
Purchase of Investments		 -212 -89 -12 -195 -59 -171 -174 0.00 -185 -187 -208
Sale of Property, Plant & Equipment		 0.63 0.27 1.64 2.27 0.69 6.48 3.01 0.59 0.10 0.06 0.00
Sale and/or Maturity of Investments		 90 102 176 69 190 136 104 68 183 175 208
Net Cash From Financing Activities		 332 12 4.28 310 8.14 33 121 -155 30 111 90
Net Cash From Continuing Financing Activities		 332 12 4.28 310 8.14 33 121 -155 30 111 90
Repayment of Debt		 -19 -6.02 -7.01 -4.95 -11 -12 -0.47 -155 -43 0.00 0.00
Issuance of Debt		 15 5.62 6.23 224 12 10 - - 0.00 0.00 93
Issuance of Preferred Equity		 - - - - - - - 0.00 0.00 79 -0.54
Issuance of Common Equity		 328 0.00 14 88 6.61 35 121 0.00 73 31 -0.36
Other Financing Activities, net		 6.64 12 -7.70 2.34 0.31 0.12 0.61 0.00 0.00 0.35 -1.88
Effect of Exchange Rate Changes		 0.21 -0.87 - - -0.81 0.35 0.22 -0.83 -0.32 -0.03 0.04
Cash Interest Paid		 1.20 0.96 0.62 3.87 3.75 7.20 7.16 8.54 1.17 0.01 3.51
Cash Income Taxes Paid		 1.17 0.01 0.57 0.22 0.05 0.05 0.04 0.00 0.02 0.00 0.00

Quarterly Cash Flow Statements for Precigen

This table details how cash moves in and out of Precigen's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -6.62 -2.49 9.90 -8.14 15 4.79 -23 7.70 0.56 16 -23
Net Cash From Operating Activities		 -17 -16 -14 -23 -23 -8.24 -16 -19 -29 -23 -44
Net Cash From Continuing Operating Activities		 -17 -16 -14 -23 -23 -8.24 -16 -19 -29 -23 -44
Net Income / (Loss) Continuing Operations		 -20 -33 -24 -59 -24 -20 -54 -27 -146 -24 -7.93
Consolidated Net Income / (Loss)		 -20 -33 -24 -59 -24 -20 -54 -27 -146 -24 -7.93
Depreciation Expense		 1.65 1.61 1.60 1.60 0.67 0.66 0.63 -32 0.80 1.14 1.10
Amortization Expense		 -0.57 -0.52 -0.40 -0.17 -0.16 -0.15 -0.71 -0.47 -0.25 -0.43 -0.02
Non-Cash Adjustments To Reconcile Net Income		 1.61 0.09 3.11 35 5.00 8.94 36 34 116 1.43 1.06
Changes in Operating Assets and Liabilities, net		 0.10 16 5.34 -0.41 -4.27 2.04 2.22 6.40 0.83 -2.09 -38
Net Cash From Investing Activities		 11 13 24 15 5.65 -65 -6.46 28 -63 40 21
Net Cash From Continuing Investing Activities		 11 13 24 15 5.65 -65 -6.46 28 -63 40 21
Purchase of Property, Plant & Equipment		 -0.24 -1.05 -4.35 -2.32 -0.88 -1.03 -0.62 -0.97 -0.39 -0.02 -0.26
Purchase of Investments		 -25 -31 -17 -34 -23 -112 -10 -28 -145 -24 -34
Sale and/or Maturity of Investments		 36 46 46 52 30 48 4.57 58 82 64 55
Net Cash From Financing Activities		 - - 0.00 0.05 32 78 -0.68 -1.77 93 -0.51 0.11
Net Cash From Continuing Financing Activities		 - - 0.00 0.05 32 78 -0.68 -1.77 93 -0.51 0.11
Issuance of Common Equity		 - - 0.00 - 32 -0.60 -0.36 - - - 0.00
Other Financing Activities, net		 - - 0.00 - 0.29 - -0.32 -1.23 -0.47 0.14 0.11
Effect of Exchange Rate Changes		 -0.13 -0.01 -0.06 -0.04 0.07 -0.00 0.00 0.00 0.01 0.02 -0.00
Cash Interest Paid		 0.00 0.01 0.00 0.00 0.00 - 0.00 - 0.83 2.68 2.56

Annual Balance Sheets for Precigen

This table presents Precigen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 982 949 847 716 456 315 360 216 151 145 156
Total Current Assets		 324 315 154 285 235 149 157 118 69 102 115
Cash & Equivalents		 136 63 68 97 66 52 36 4.86 7.58 30 30
Short-Term Investments		 103 175 12 120 9.26 48 72 51 55 68 68
Accounts Receivable		 52 41 40 27 23 17 1.98 14 1.58 1.16 4.36
Inventories, net		 27 21 20 21 16 11 0.33 - - 0.00 9.58
Prepaid Expenses		 6.63 7.36 7.06 5.33 5.83 7.19 5.47 5.07 4.33 3.34 3.43
Plant, Property, & Equipment, net		 43 65 113 87 44 35 8.60 7.33 7.11 14 14
Total Noncurrent Assets		 616 569 580 344 177 131 195 90 75 29 27
Long-Term Investments		 199 183 180 2.14 1.46 0.00 49 - - 0.00 2.51
Goodwill		 165 157 153 94 54 54 38 37 27 19 15
Intangible Assets		 248 226 233 89 68 65 52 44 41 4.46 3.18
Other Noncurrent Operating Assets		 3.73 3.71 14 2.71 13 11 11 9.11 7.86 5.43 5.59
Total Liabilities & Shareholders' Equity		 982 949 847 716 456 315 360 216 151 145 156
Total Liabilities		 277 380 300 337 384 247 253 90 33 79 135
Total Current Liabilities		 76 95 80 62 123 42 35 79 23 22 37
Accounts Payable		 5.12 8.92 9.01 12 5.58 4.62 3.19 4.07 1.73 3.53 12
Accrued Expenses		 7.95 16 21 19 12 9.55 7.82 5.00 6.22 4.81 11
Current Deferred Revenue		 42 62 43 11 5.70 2.80 1.49 0.03 0.51 0.59 0.52
Current Employee Benefit Liabilities		 19 6.54 6.47 9.96 13 8.10 7.86 6.38 8.25 8.42 10
Other Current Liabilities		 - - - 0.00 2.63 2.66 1.39 20 6.28 4.17 3.61
Total Noncurrent Liabilities		 201 285 220 276 261 205 218 11 9.56 57 97
Long-Term Debt		 7.60 7.56 7.54 211 186 172 180 - - 0.00 93
Other Noncurrent Operating Liabilities		 9.49 3.87 3.45 3.14 10 7.84 8.75 6.99 5.90 55 4.11
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 705 569 547 379 72 67 107 126 118 39 21
Total Preferred & Common Equity		 694 560 534 363 72 67 107 126 118 39 21
Total Common Equity		 694 560 534 363 72 67 107 126 118 39 21
Common Stock		 1,250 1,326 1,397 1,722 1,752 1,887 2,023 1,998 2,085 2,129 2,362
Retained Earnings		 -543 -729 -848 -1,331 -1,653 -1,823 -1,916 -1,869 -1,964 -2,091 -2,341
Accumulated Other Comprehensive Income / (Loss)		 -13 -36 -16 -29 -27 4.00 0.20 -3.49 -1.95 0.01 0.01

Quarterly Balance Sheets for Precigen

This table presents Precigen's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 259 242 208 191 135 73 83 129 102 171 139
Total Current Assets		 163 138 106 93 50 24 35 85 63 130 102
Cash & Equivalents		 9.07 9.74 17 10 17 9.35 25 6.06 14 14 7.48
Short-Term Investments		 62 94 72 64 27 10 3.91 74 46 107 49
Accounts Receivable		 2.45 16 14 14 1.16 1.02 0.73 1.06 0.57 1.10 27
Inventories, net		 0.22 - - - - - - - - 3.06 15
Prepaid Expenses		 6.36 4.33 2.79 5.13 3.63 3.16 5.15 3.30 2.43 4.30 4.00
Plant, Property, & Equipment, net		 7.61 6.91 6.57 7.12 13 13 14 15 15 15 13
Total Noncurrent Assets		 89 97 95 91 73 36 35 30 24 27 24
Long-Term Investments		 0.00 7.46 7.13 5.27 - - - 0.75 - 2.51 0.49
Goodwill		 37 37 37 37 27 25 25 19 15 15 15
Intangible Assets		 42 44 43 40 39 5.09 4.77 4.14 3.82 3.50 2.86
Other Noncurrent Operating Assets		 9.70 8.62 8.57 7.99 7.41 5.99 5.73 5.49 5.40 5.61 5.15
Total Liabilities & Shareholders' Equity		 259 242 208 191 135 73 83 129 102 171 139
Total Liabilities		 117 57 41 43 38 30 28 113 108 129 118
Total Current Liabilities		 105 47 31 33 29 23 21 24 23 32 21
Accounts Payable		 4.20 3.81 2.51 2.35 4.72 4.85 4.32 3.11 3.92 6.26 2.59
Accrued Expenses		 12 23 3.26 4.12 7.30 6.64 5.68 6.57 9.51 11 12
Current Deferred Revenue		 0.08 0.02 0.02 0.51 0.41 0.38 0.41 0.55 0.41 0.48 0.41
Current Employee Benefit Liabilities		 5.79 4.96 4.82 6.62 9.96 6.68 6.61 9.62 5.20 10 4.56
Other Current Liabilities		 1.04 1.24 20 19 6.39 4.48 4.20 4.14 4.14 4.34 1.07
Total Noncurrent Liabilities		 12 11 11 10 9.05 6.97 6.88 89 85 97 97
Long-Term Debt		 0.00 - - - - - - - - 93 94
Other Noncurrent Operating Liabilities		 7.94 6.62 6.55 6.19 5.39 5.07 4.76 88 83 4.34 3.77
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 143 184 166 148 97 43 55 -14 -37 42 20
Total Preferred & Common Equity		 143 184 166 148 97 43 55 -14 -37 42 20
Total Common Equity		 143 184 166 148 97 43 55 -14 -37 42 20
Common Stock		 1,996 2,078 2,080 2,083 2,088 2,093 2,126 2,131 2,135 2,360 2,370
Retained Earnings		 -1,846 -1,891 -1,912 -1,931 -1,988 -2,047 -2,071 -2,145 -2,172 -2,318 -2,349
Accumulated Other Comprehensive Income / (Loss)		 -7.18 -2.70 -2.52 -3.56 -2.80 -2.91 0.01 0.01 0.01 0.02 -0.02

Annual Metrics And Ratios for Precigen

This table displays calculated financial ratios and metrics derived from Precigen's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 116,397,980.00 118,575,964.00 120,720,505.00 137,221,526.00 162,682,637.00 185,462,551.00 206,738,499.00 - - - 353,824,499.00
DEI Adjusted Shares Outstanding		 117,646,152.00 119,847,492.00 120,720,505.00 137,221,526.00 162,682,637.00 185,462,551.00 206,738,499.00 - - - 353,824,499.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.72 -1.56 -0.97 -3.71 -4.21 -0.92 -0.45 - - - -1.21
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 141.35% 9.98% 0.00% 0.00% 0.00% 0.00% -55.40% 88.61% -76.87% -100.00% 146.73%
EBITDA Growth		 -305.19% 79.94% 100.00% -212.23% 63.97% 123.89% -311.36% 6.25% -52.35% -25.09% -97.65%
EBIT Growth		 -107.54% 15.17% 100.00% -187.29% 61.81% 102.24% -2,626.11% 19.69% -33.02% -22.55% -93.13%
NOPAT Growth		 -109.92% 14.77% 100.00% -285.43% 54.88% 103.24% -1,803.70% 17.64% -31.15% -35.96% 18.16%
Net Income Growth		 -2.78% -116.24% 0.00% -305.86% 0.00% 90.17% -45.11% 138.07% -373.30% -31.63% -98.55%
EPS Growth		 8.43% -107.89% 0.00% 0.00% 0.00% 0.00% 0.00% 129.79% -378.57% -20.51% -191.49%
Operating Cash Flow Growth		 279.62% -237.34% 0.00% -19.78% -9.41% 43.34% 27.59% -16.63% -2.90% -1.86% -28.84%
Free Cash Flow Firm Growth		 -65.21% 114.10% -461.69% 7.22% 86.31% 55.61% 253.53% -451.38% 11.48% 86.00% -1,488.01%
Invested Capital Growth		 149.75% -45.37% 90.64% -24.09% -41.53% 11.96% -57.32% 14.88% -20.72% -156.03% 143.99%
Revenue Q/Q Growth		 6.38% 2.42% 0.00% 0.00% 0.00% 0.00% -50.62% 165.10% -7.91% -100.00% 24.33%
EBITDA Q/Q Growth		 -56.53% 77.51% 100.00% -164.84% -1,678.55% 6.10% -673.73% -6.84% -16.41% 15.64% -0.56%
EBIT Q/Q Growth		 -289.43% 48.65% 100.00% -103.58% -291.45% 228.72% -512.56% 1.09% -14.27% 15.59% -0.64%
NOPAT Q/Q Growth		 -11.74% 1.42% 100.00% -141.03% 0.00% 0.00% -789.16% 5.86% -13.72% 3.75% 5.84%
Net Income Q/Q Growth		 -139.20% -6.51% 0.00% -148.74% 0.00% 89.76% -5,054.70% 37.83% -22.56% 9.55% -1.53%
EPS Q/Q Growth		 -181.48% -4.64% 0.00% 0.00% 42.27% 0.00% 0.00% 16.67% -5.41% 14.55% 0.72%
Operating Cash Flow Q/Q Growth		 149.66% -151.89% 0.00% -2.88% 3.70% 16.91% 3.26% -1.26% -0.56% 9.94% -20.96%
Free Cash Flow Firm Q/Q Growth		 5.19% -50.55% 34.07% -12.52% -111.51% -106.34% 775.22% -2,212.36% 6.75% 86.33% -83.78%
Invested Capital Q/Q Growth		 -9.68% 7.33% 16.28% -29.16% -60.17% 2.72% -53.03% -0.91% -18.95% -216.58% 23.40%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 63.18% 67.72% 0.00% 0.00% 0.00% 83.20% 59.73% 76.44% 1.70% 0.00% 50.20%
EBITDA Margin		 -111.77% -20.39% 0.00% 0.00% 0.00% 97.09% -460.17% -228.73% -1,506.30% 0.00% -2,567.50%
Operating Margin		 -84.60% -65.56% 0.00% 0.00% 0.00% 11.43% -644.48% -281.42% -1,595.39% 0.00% -1,141.13%
EBIT Margin		 -83.84% -64.67% 0.00% 0.00% 0.00% 11.43% -647.51% -275.70% -1,585.32% 0.00% -2,581.44%
Profit (Net Income) Margin		 -50.69% -99.66% 0.00% 0.00% 0.00% -198.54% -646.01% 130.41% -1,540.63% 0.00% -2,588.21%
Tax Burden Percent		 101.17% 98.00% 0.00% 65.00% 188.67% -2,560.10% 83.06% -43.88% 99.52% 98.60% 100.00%
Interest Burden Percent		 59.76% 157.25% 0.00% 185.15% 209.70% 67.84% 120.12% 107.79% 97.65% 105.86% 100.26%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% -3.31% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -53.08% -40.97% 0.00% 0.00% 0.00% 2.79% -63.03% -80.75% -110.50% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -57.16% -16.72% 0.00% 0.00% 0.00% -99.10% -250.21% -252.95% -66.12% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 37.29% 11.10% 0.00% 0.00% 0.00% -94.25% -42.59% 110.80% 32.13% 0.00% 0.00%
Return on Equity (ROE)		 -15.80% -29.87% 0.00% -111.26% -286.94% -91.47% -105.62% 30.04% -78.37% -136.30% -571.97%
Cash Return on Invested Capital (CROIC)		 -138.71% 17.71% -62.37% -74.74% -14.97% -8.50% 17.31% -94.61% -87.38% 0.00% -891.29%
Operating Return on Assets (OROA)		 -18.68% -12.79% 0.00% 0.00% 0.00% 0.95% -27.39% -25.77% -53.78% 0.00% -166.23%
Return on Assets (ROA)		 -11.29% -19.71% 0.00% 0.00% 0.00% -16.49% -27.33% 12.19% -52.26% 0.00% -166.67%
Return on Common Equity (ROCE)		 -15.29% -29.40% 0.00% -107.80% -276.83% -91.47% -105.62% 30.04% -78.37% -115.54% -387.81%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% -141.85% 0.00% 0.00% 0.00% 27.79% -80.93% -327.77% 0.00%
Net Operating Profit after Tax (NOPAT)		 -103 -88 0.00 -259 -117 3.78 -64 -53 -70 -95 -77
NOPAT Margin		 -59.22% -45.89% 0.00% 0.00% 0.00% 11.81% -451.14% -196.99% -1,116.77% 0.00% -798.79%
Net Nonoperating Expense Percent (NNEP)		 4.08% -24.26% 0.00% -122.30% -1,018.99% 101.89% 187.18% 172.20% -44.37% -39.45% -329.74%
Return On Investment Capital (ROIC_SIMPLE)		 -14.40% -15.16% - - -40.04% 1.58% -22.40% -31.28% -58.67% -245.42% -67.80%
Cost of Revenue to Revenue		 36.82% 32.28% 0.00% 0.00% 0.00% 16.80% 40.27% 23.56% 98.30% 0.00% 49.80%
SG&A Expenses to Revenue		 62.82% 74.54% 0.00% 0.00% 0.00% 0.00% 364.44% 178.40% 649.24% 0.00% 724.16%
R&D to Revenue		 84.95% 58.73% 0.00% 0.00% 0.00% 0.00% 335.97% 175.29% 780.95% 0.00% 426.82%
Operating Expenses to Revenue		 147.77% 133.27% 0.00% 0.00% 0.00% 71.77% 708.02% 357.86% 1,597.09% 0.00% 1,191.33%
Earnings before Interest and Taxes (EBIT)		 -146 -123 0.00 -428 -163 3.66 -92 -74 -99 -121 -250
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -194 -39 0.00 -361 -130 31 -66 -62 -94 -117 -249
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.06 5.14 0.00 0.00 12.43 28.16 7.15 2.51 2.81 8.52 70.73
Price to Tangible Book Value (P/TBV)		 12.47 16.24 0.00 0.00 0.00 0.00 43.82 7.05 6.52 21.99 592.31
Price to Revenue (P/Rev)		 20.21 15.09 0.00 0.00 0.00 59.13 53.76 11.76 53.58 0.00 152.72
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11.17 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 8.95% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 11.18 16.36 0.00 0.01 8.10 13.72 12.93 3.71 4.86 0.00 107.30
Enterprise Value to Revenue (EV/Rev)		 17.81 12.95 0.00 0.00 0.00 61.37 55.35 9.67 43.49 0.00 151.98
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 63.21 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 536.91 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 519.73 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 86.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 65.29 0.00 0.00 0.00 0.00 44.68 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.01 0.02 0.02 0.56 3.07 2.56 1.68 0.34 0.00 0.00 4.46
Long-Term Debt to Equity		 0.01 0.01 0.01 0.56 2.60 2.55 1.68 0.00 0.00 0.00 4.46
Financial Leverage		 -0.65 -0.66 -0.61 -0.45 -0.23 0.95 0.17 -0.44 -0.49 -0.87 -1.20
Leverage Ratio		 1.40 1.52 1.61 1.69 2.60 5.55 3.86 2.47 1.50 1.60 3.43
Compound Leverage Factor		 0.84 2.38 0.00 3.13 5.46 3.76 4.64 2.66 1.46 1.69 3.44
Debt to Total Capital		 1.27% 1.52% 1.49% 35.91% 75.41% 71.90% 62.63% 25.50% 0.00% 0.00% 81.67%
Short-Term Debt to Total Capital		 0.21% 0.21% 0.13% 0.16% 11.52% 0.15% 0.02% 25.50% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 1.06% 1.31% 1.36% 35.75% 63.89% 71.75% 62.62% 0.00% 0.00% 0.00% 81.67%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 1.51% 1.56% 2.33% 2.69% 0.00% 0.00% 0.00% 0.00% 0.00% 42.29% 0.00%
Common Equity to Total Capital		 97.21% 96.92% 96.18% 61.41% 24.59% 28.10% 37.37% 74.50% 100.00% 57.71% 18.33%
Debt to EBITDA		 -0.05 -0.23 0.00 -0.59 -1.69 5.53 -2.74 -0.70 0.00 0.00 -0.37
Net Debt to EBITDA		 2.21 10.74 0.00 0.04 -1.10 2.31 -0.35 0.91 0.00 0.00 0.03
Long-Term Debt to EBITDA		 -0.04 -0.19 0.00 -0.59 -1.43 5.52 -2.74 0.00 0.00 0.00 -0.37
Debt to NOPAT		 -0.09 -0.10 0.00 -0.82 -1.88 45.50 -2.80 -0.82 0.00 0.00 -1.20
Net Debt to NOPAT		 4.17 4.77 0.00 0.05 -1.23 19.00 -0.35 1.06 0.00 0.00 0.09
Long-Term Debt to NOPAT		 -0.07 -0.09 0.00 -0.82 -1.60 45.40 -2.79 0.00 0.00 0.00 -1.20
Altman Z-Score		 6.81 3.53 -1.30 -4.20 -4.57 -2.98 -6.03 -10.79 -13.81 -19.72 -19.13
Noncontrolling Interest Sharing Ratio		 3.17% 1.56% 1.97% 3.11% 3.52% 0.00% 0.00% 0.00% 0.00% 15.23% 32.20%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.27 3.33 1.92 4.64 1.91 3.54 4.52 1.50 2.99 4.76 3.09
Quick Ratio		 3.83 2.96 1.49 3.95 0.82 2.86 3.19 0.89 2.80 4.60 2.74
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -269 38 -137 -189 -26 -12 18 -62 -55 -7.70 -122
Operating Cash Flow to CapEx		 294.23% -156.24% 0.00% -315.97% -365.44% -7,384.56% -1,315.04% -1,502.19% -4,654.38% -799.78% -4,402.56%
Free Cash Flow to Firm to Interest Expense		 -215.95 43.98 0.00 -22.35 -1.47 0.00 0.94 0.00 0.00 0.00 -31.61
Operating Cash Flow to Interest Expense		 28.67 -56.90 0.00 -14.66 -7.69 0.00 -2.97 0.00 0.00 0.00 -22.71
Operating Cash Flow Less CapEx to Interest Expense		 18.93 -93.31 0.00 -19.30 -9.80 0.00 -3.20 0.00 0.00 0.00 -23.23
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.22 0.20 0.00 0.00 0.00 0.08 0.04 0.09 0.03 0.00 0.06
Accounts Receivable Turnover		 4.37 4.12 0.00 0.00 0.00 1.60 1.52 3.41 0.81 0.00 3.51
Inventory Turnover		 2.44 2.58 0.00 0.00 3.35 0.39 0.98 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 4.30 3.56 0.00 0.00 0.00 0.81 0.66 3.38 0.86 0.00 0.70
Accounts Payable Turnover		 11.02 8.78 0.00 0.00 6.90 1.05 1.47 1.75 2.11 1.62 0.62
Days Sales Outstanding (DSO)		 83.53 88.59 0.00 0.00 0.00 228.28 239.44 107.05 450.87 0.00 104.12
Days Inventory Outstanding (DIO)		 149.45 141.24 0.00 0.00 109.00 932.40 371.19 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 33.11 41.55 0.00 0.00 52.93 346.25 247.88 208.84 172.81 224.84 587.12
Cash Conversion Cycle (CCC)		 199.87 188.27 0.00 0.00 0.00 814.43 362.75 -101.79 278.06 0.00 -483.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 277 151 288 219 128 143 61 70 56 -31 14
Invested Capital Turnover		 0.90 0.89 0.00 0.00 0.00 0.24 0.14 0.41 0.10 0.00 -1.11
Increase / (Decrease) in Invested Capital		 166 -125 137 -69 -91 15 -82 9.09 -15 -87 45
Enterprise Value (EV)		 3,092 2,472 -246 2.03 1,035 1,963 790 260 271 258 1,472
Market Capitalization		 3,509 2,881 0.00 0.00 892 1,892 767 316 334 328 1,479
Book Value per Share		 $5.96 $4.72 $0.00 $0.00 $0.44 $0.36 $0.52 $0.61 $0.48 $0.13 $0.06
Tangible Book Value per Share		 $2.42 $1.50 $0.00 $0.00 ($0.31) ($0.28) $0.08 $0.22 $0.21 $0.05 $0.01
Total Capital		 714 578 555 591 292 239 287 169 118 67 114
Total Debt		 9.09 8.77 8.27 212 220 172 180 43 0.00 0.00 93
Total Long-Term Debt		 7.60 7.56 7.54 211 186 172 180 0.00 0.00 0.00 93
Net Debt		 -428 -418 -258 -14 143 72 23 -56 -63 -98 -7.20
Capital Expenditures (CapEx)		 12 31 0.00 39 37 1.04 4.24 4.33 1.44 8.52 2.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 11 -22 -12 1.01 70 7.06 13 -17 -17 -17 -20
Debt-free Net Working Capital (DFNWC)		 249 222 75 225 145 107 122 83 46 81 78
Net Working Capital (NWC)		 248 221 74 224 112 107 122 40 46 81 78
Net Nonoperating Expense (NNE)		 -15 103 0.00 256 529 67 28 -88 26 32 173
Net Nonoperating Obligations (NNO)		 -428 -418 -258 -160 56 76 -46 -56 -63 -98 -7.20
Total Depreciation and Amortization (D&A)		 -48 85 0.00 67 33 27 27 13 4.92 3.64 1.35
Debt-free, Cash-free Net Working Capital to Revenue		 6.38% -11.74% 0.00% 0.00% 0.00% 22.08% 93.73% -61.53% -274.46% 0.00% -205.79%
Debt-free Net Working Capital to Revenue		 143.65% 116.16% 0.00% 0.00% 0.00% 335.02% 855.37% 307.45% 735.26% 0.00% 804.72%
Net Working Capital to Revenue		 142.79% 115.53% 0.00% 0.00% 0.00% 333.90% 855.00% 146.84% 735.26% 0.00% 804.72%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.75) ($1.58) $0.00 $0.00 $0.00 ($1.02) ($0.47) $0.14 ($0.39) ($0.47) ($1.37)
Adjusted Weighted Average Basic Shares Outstanding		 118.03M 118.73M 0.00 0.00 0.00 205.66M 197.76M 200.36M 244.54M 267.73M 312.98M
Adjusted Diluted Earnings per Share		 ($0.75) ($1.58) $0.00 $0.00 $0.00 ($1.02) ($0.47) $0.14 ($0.39) ($0.47) ($1.37)
Adjusted Weighted Average Diluted Shares Outstanding		 118.03M 118.73M 0.00 0.00 0.00 205.66M 197.76M 200.36M 244.54M 267.73M 312.98M
Adjusted Basic & Diluted Earnings per Share		 ($0.75) ($1.58) $0.00 ($3.93) ($2.09) ($1.02) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 112.26M 117.98M 0.00 129.52M 154.14M 167.07M 206.93M 252.19M 248.92M 294.04M 353.93M
Normalized Net Operating Profit after Tax (NOPAT)		 -103 -88 0.00 -259 -11 19 -64 -52 -62 -61 -75
Normalized NOPAT Margin		 -59.22% -45.89% 0.00% 0.00% 0.00% 58.24% -448.47% -194.08% -999.94% 0.00% -770.55%
Pre Tax Income Margin		 -50.10% -101.69% 0.00% 0.00% 0.00% 7.76% -777.79% -297.17% -1,547.98% 0.00% -2,588.18%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -117.00 -143.40 0.00 -50.47 -9.25 0.00 -4.93 0.00 0.00 0.00 -64.65
NOPAT to Interest Expense		 -82.64 -101.76 0.00 -30.54 -6.61 0.00 -3.43 0.00 0.00 0.00 -20.00
EBIT Less CapEx to Interest Expense		 -126.75 -179.82 0.00 -55.12 -11.35 0.00 -5.15 0.00 0.00 0.00 -65.16
NOPAT Less CapEx to Interest Expense		 -92.39 -138.18 0.00 -35.18 -8.71 0.00 -3.66 0.00 0.00 0.00 -20.52
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Precigen

This table displays calculated financial ratios and metrics derived from Precigen's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - 294,042,973.00 295,180,060.00 297,972,920.00 353,824,499.00 353,928,672.00
DEI Adjusted Shares Outstanding		 - - - - - - 294,042,973.00 295,180,060.00 297,972,920.00 353,824,499.00 353,928,672.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - -0.18 -0.09 -1.09 -0.07 -0.02
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -91.75% -30.35% -42.46% -18.85% -30.89% -381.11% 151.83% 19.39% 206.61% 400.63% 1,633.93%
EBITDA Growth		 -457.33% -67.64% -7.51% -198.74% -21.23% 66.38% 2.20% -0.47% -512.68% -7.10% 91.61%
EBIT Growth		 -214.11% -57.22% -5.52% -188.47% -17.38% 65.97% -125.95% 55.04% -502.04% -7.91% 89.64%
NOPAT Growth		 -174.98% -54.97% -3.97% -188.07% -1.55% 15.58% 7.43% 47.79% -62.17% 24.02% 73.47%
Net Income Growth		 -122.65% -114.62% -4.42% -189.34% -21.13% 40.32% -128.13% 54.68% -510.33% -19.14% 85.36%
EPS Growth		 -118.18% -18.18% 0.00% -187.50% -12.50% 61.54% -80.00% 60.87% -1,077.78% 20.00% 88.89%
Operating Cash Flow Growth		 28.58% -2.40% 23.37% -46.54% -33.66% 47.72% -15.86% 17.87% -27.87% -184.61% -168.47%
Free Cash Flow Firm Growth		 -123.14% 62.64% -92.64% 113.78% 316.59% 834.85% 3,034.88% 1,414.77% -131.48% -189.83% -224.29%
Invested Capital Growth		 -3.08% -20.72% -28.02% -66.55% -61.04% -156.03% -225.40% -377.77% -58.44% 143.99% 187.01%
Revenue Q/Q Growth		 -21.96% -10.95% -13.27% 34.65% -33.54% -462.22% 467.02% -36.17% 70.68% -18.96% 881.93%
EBITDA Q/Q Growth		 1.49% -67.31% 29.25% -156.20% 60.03% 53.60% -16.16% -163.19% -143.77% 85.63% 77.85%
EBIT Q/Q Growth		 1.99% -63.90% 28.01% -149.45% 60.12% 52.48% -175.05% 50.36% -434.03% 85.20% 73.60%
NOPAT Q/Q Growth		 0.87% -61.33% 27.73% -149.25% 65.05% -34.12% 20.76% -40.57% -8.55% 37.17% 72.33%
Net Income Q/Q Growth		 2.58% -66.99% 28.19% -147.67% 59.22% 17.73% -174.51% 50.80% -449.30% 83.94% 66.26%
EPS Q/Q Growth		 0.00% -62.50% 23.08% -130.00% 60.87% 44.44% -260.00% 50.00% -1,077.78% 96.23% 50.00%
Operating Cash Flow Q/Q Growth		 -7.86% 7.30% 10.63% -64.00% 1.62% 63.74% -98.05% -16.25% -53.18% 19.30% -86.82%
Free Cash Flow Firm Q/Q Growth		 61.17% 27.08% 135.75% 36.07% 510.52% 147.42% 52.52% -34.25% -112.69% -606.05% -111.03%
Invested Capital Q/Q Growth		 -2.83% -18.95% -6.08% -54.78% 13.16% -216.58% -110.19% -0.18% 116.93% 23.40% 315.71%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 -11.46% -10.59% -0.94% 29.29% -5.88% 0.00% 58.99% 36.22% 64.58% 32.60% 88.99%
EBITDA Margin		 -1,419.80% -2,667.51% -2,176.06% -4,140.52% -2,490.56% 0.00% -845.12% -3,484.46% -4,976.69% -882.52% -19.91%
Operating Margin		 -1,518.27% -2,750.65% -2,292.02% -4,242.75% -2,231.06% 0.00% -842.51% -1,855.37% -1,180.05% -914.95% -25.78%
EBIT Margin		 -1,497.90% -2,757.00% -2,288.54% -4,239.75% -2,544.28% 0.00% -2,053.32% -1,596.67% -4,995.76% -912.42% -24.53%
Profit (Net Income) Margin		 -1,435.46% -2,691.86% -2,228.92% -4,099.86% -2,516.05% 0.00% -2,019.13% -1,556.19% -5,008.35% -992.53% -34.10%
Tax Burden Percent		 99.97% 99.01% 99.88% 97.21% 100.05% 99.56% 100.00% 100.01% 100.00% 100.00% 100.00%
Interest Burden Percent		 95.86% 98.62% 97.51% 99.48% 98.84% 171.97% 98.33% 97.45% 100.25% 108.78% 139.01%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -103.02% -190.51% -139.78% -321.68% -153.23% 0.00% 0.00% 0.00% -339.88% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -96.20% -174.68% -131.27% -293.52% -136.34% 0.00% 0.00% 0.00% 71.70% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 49.96% 84.88% 72.97% 161.35% 72.28% 0.00% 0.00% 0.00% -43.79% 0.00% 0.00%
Return on Equity (ROE)		 -53.05% -105.63% -66.81% -160.33% -80.95% -136.30% -278.55% -668.03% -383.67% -571.97% -1,145.42%
Cash Return on Invested Capital (CROIC)		 -84.53% -87.38% -79.82% -108.10% -118.03% 0.00% 0.00% 0.00% -351.40% -891.29% -330.22%
Operating Return on Assets (OROA)		 -45.01% -93.52% -66.14% -154.25% -86.86% 0.00% -86.33% -106.17% -305.51% -58.75% -5.80%
Return on Assets (ROA)		 -43.13% -91.31% -64.42% -149.16% -85.90% 0.00% -84.89% -103.48% -306.28% -63.91% -8.06%
Return on Common Equity (ROCE)		 -53.05% -105.63% -66.81% -160.33% -80.95% -115.54% -205.45% -114.54% -383.67% -387.81% -198.16%
Return on Equity Simple (ROE_SIMPLE)		 -52.99% 0.00% -99.89% -313.60% -252.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -15 -24 -17 -43 -15 -20 -16 -22 -24 -15 -4.20
NOPAT Margin		 -1,062.79% -1,925.46% -1,604.41% -2,969.92% -1,561.74% 0.00% -589.75% -1,298.76% -826.03% -640.46% -18.04%
Net Nonoperating Expense Percent (NNEP)		 -6.82% -15.83% -8.51% -28.16% -16.90% 0.29% -60.97% -11.12% -411.58% -15.86% -16.89%
Return On Investment Capital (ROIC_SIMPLE)		 -9.92% -19.95% -17.61% -98.65% -26.88% -51.83% 112.50% 60.46% -17.91% -13.29% -3.69%
Cost of Revenue to Revenue		 111.46% 110.59% 100.94% 70.71% 105.88% 0.00% 41.01% 63.79% 35.42% 67.40% 11.01%
SG&A Expenses to Revenue		 666.86% 835.83% 953.15% 718.69% 1,032.11% 0.00% 460.81% 942.35% 821.05% 745.14% 90.53%
R&D to Revenue		 839.96% 1,058.14% 1,337.93% 1,094.35% 1,193.07% 0.00% 390.68% 671.03% 423.58% 295.19% 24.25%
Operating Expenses to Revenue		 1,506.82% 2,740.07% 2,291.08% 4,335.70% 2,225.18% 0.00% 851.49% 1,841.59% 1,244.63% 1,040.33% 114.77%
Earnings before Interest and Taxes (EBIT)		 -21 -34 -24 -61 -24 -12 -55 -27 -146 -22 -5.70
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -20 -33 -23 -59 -24 -11 -23 -60 -145 -21 -4.63
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.46 2.81 3.72 9.24 4.32 8.52 0.00 0.00 23.41 70.73 67.69
Price to Tangible Book Value (P/TBV)		 5.16 6.52 11.37 30.30 9.32 21.99 0.00 0.00 42.37 592.31 640.35
Price to Revenue (P/Rev)		 53.67 53.58 66.36 78.11 51.15 0.00 79.06 72.02 125.86 152.72 43.35
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 4.13 4.86 6.05 16.05 7.88 0.00 0.00 0.00 85.43 107.30 24.67
Enterprise Value to Revenue (EV/Rev)		 41.98 43.49 58.13 74.28 45.03 0.00 69.77 67.06 121.91 151.98 44.52
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 15.75 23.82 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.22 4.46 4.62
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.22 4.46 4.62
Financial Leverage		 -0.52 -0.49 -0.56 -0.55 -0.53 -0.87 -1.12 -2.13 -0.61 -1.20 -1.24
Leverage Ratio		 1.55 1.50 1.34 1.34 1.35 1.60 2.34 4.70 2.62 3.43 7.49
Compound Leverage Factor		 1.49 1.48 1.31 1.33 1.33 2.75 2.30 4.58 2.63 3.73 10.41
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 68.93% 81.67% 82.21%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 68.93% 81.67% 82.21%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 42.29% 190.96% -523.80% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 57.71% -90.96% 623.80% 31.07% 18.33% 17.79%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 -0.37 -0.47
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12 0.03 -0.19
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 -0.37 -0.47
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.13 -1.20 -1.42
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.37 0.09 -0.56
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.13 -1.20 -1.42
Altman Z-Score		 -9.06 -12.39 -15.29 -33.85 -30.33 -17.24 -21.80 -27.86 -16.49 -14.28 -15.99
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 15.23% 26.24% 82.85% 0.00% 32.20% 82.70%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.83 2.99 1.72 1.03 1.63 4.76 3.53 2.71 4.04 3.09 4.82
Quick Ratio		 2.67 2.80 1.60 0.89 1.38 4.60 3.39 2.60 3.81 2.74 3.93
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -12 -9.10 3.25 4.43 27 67 102 67 -8.51 -60 -127
Operating Cash Flow to CapEx		 -7,206.78% -1,564.09% -324.06% -994.71% -2,755.52% -801.85% -2,624.60% -1,964.49% -7,472.75% -130,333.33% -16,987.21%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 1,626.50 0.00 0.00 0.00 101,977.80 0.00 0.00 0.00 -43.59
Operating Cash Flow to Interest Expense		 0.00 0.00 -7,045.00 0.00 0.00 0.00 -16,325.00 0.00 0.00 0.00 -15.07
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 -9,219.00 0.00 0.00 0.00 -16,947.00 0.00 0.00 0.00 -15.16
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.03 0.03 0.03 0.04 0.03 0.00 0.04 0.07 0.06 0.06 0.24
Accounts Receivable Turnover		 0.82 0.81 0.65 0.66 0.63 0.00 4.98 7.33 8.52 3.51 2.28
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.92 0.86 0.56 0.51 0.45 0.00 0.41 0.41 0.55 0.70 2.27
Accounts Payable Turnover		 1.84 2.11 1.33 1.36 1.34 1.62 1.10 1.00 0.83 0.62 2.21
Days Sales Outstanding (DSO)		 447.04 450.87 559.81 551.22 578.46 0.00 73.30 49.76 42.85 104.12 160.40
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 198.69 172.81 274.54 269.36 273.22 224.84 332.64 366.17 439.31 587.12 165.48
Cash Conversion Cycle (CCC)		 248.35 278.06 285.28 281.86 305.25 0.00 -259.34 -316.41 -396.46 -483.00 -5.08
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 69 56 52 24 27 -31 -66 -66 11 14 57
Invested Capital Turnover		 0.10 0.10 0.09 0.11 0.10 0.00 -0.84 -0.28 0.41 -1.11 -7.42
Increase / (Decrease) in Invested Capital		 -2.18 -15 -20 -47 -42 -87 -118 -89 -16 45 123
Enterprise Value (EV)		 284 271 316 379 211 258 387 390 950 1,472 1,406
Market Capitalization		 363 334 361 399 239 328 438 419 980 1,479 1,370
Book Value per Share		 $0.58 $0.48 $0.39 $0.17 $0.22 $0.13 ($0.05) ($0.12) $0.14 $0.06 $0.06
Tangible Book Value per Share		 $0.28 $0.21 $0.13 $0.05 $0.10 $0.05 ($0.13) ($0.19) $0.08 $0.01 $0.01
Total Capital		 148 118 97 43 55 67 15 -5.90 135 114 114
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 93 93 94
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 93 93 94
Net Debt		 -79 -63 -45 -20 -29 -98 -81 -60 -31 -7.20 37
Capital Expenditures (CapEx)		 0.24 1.01 4.35 2.32 0.83 1.03 0.62 0.97 0.39 0.02 0.26
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -14 -17 -24 -19 -15 -17 -20 -20 -24 -20 24
Debt-free Net Working Capital (DFNWC)		 60 46 21 0.69 13 81 61 40 98 78 81
Net Working Capital (NWC)		 60 46 21 0.69 13 81 61 40 98 78 81
Net Nonoperating Expense (NNE)		 5.14 9.41 6.65 16 9.09 -0.23 38 4.41 122 8.34 3.73
Net Nonoperating Obligations (NNO)		 -79 -63 -45 -20 -29 -98 -81 -60 -31 -7.20 37
Total Depreciation and Amortization (D&A)		 1.08 1.10 1.20 1.42 0.51 0.51 32 -32 0.56 0.71 1.08
Debt-free, Cash-free Net Working Capital to Revenue		 -201.80% -274.46% -441.00% -369.06% -327.65% 0.00% -354.15% -346.92% -303.08% -205.79% 76.98%
Debt-free Net Working Capital to Revenue		 889.25% 735.26% 381.91% 13.55% 284.12% 0.00% 1,093.74% 679.76% 1,252.12% 804.72% 255.00%
Net Working Capital to Revenue		 889.25% 735.26% 381.91% 13.55% 284.12% 0.00% 1,093.74% 679.76% 1,252.12% 804.72% 255.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.08) ($0.13) ($0.10) ($0.23) ($0.09) ($0.05) ($0.18) ($0.09) ($1.06) ($0.04) ($0.02)
Adjusted Weighted Average Basic Shares Outstanding		 248.52M 244.54M 249.22M 252.37M 275.88M 267.73M 293.88M 296.43M 307.17M 312.98M 354.29M
Adjusted Diluted Earnings per Share		 ($0.08) ($0.13) ($0.10) ($0.23) ($0.09) ($0.05) ($0.18) ($0.09) ($1.06) ($0.04) ($0.02)
Adjusted Weighted Average Diluted Shares Outstanding		 248.52M 244.54M 249.22M 252.37M 275.88M 267.73M 293.88M 296.43M 307.17M 312.98M 354.29M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 248.92M 248.92M 252.42M 252.76M 292.87M 294.04M 295.18M 297.97M 353.82M 353.93M 356.51M
Normalized Net Operating Profit after Tax (NOPAT)		 -15 -24 -17 -17 -15 -20 -16 -19 -24 -15 -4.20
Normalized NOPAT Margin		 -1,062.79% -1,925.46% -1,604.41% -1,204.06% -1,561.74% 0.00% -589.75% -1,139.01% -826.03% -640.46% -18.04%
Pre Tax Income Margin		 -1,435.90% -2,718.89% -2,231.64% -4,217.64% -2,514.80% 0.00% -2,019.13% -1,556.02% -5,008.35% -992.53% -34.10%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 -12,186.50 0.00 0.00 0.00 -55,070.00 0.00 0.00 0.00 -1.96
NOPAT to Interest Expense		 0.00 0.00 -8,543.50 0.00 0.00 0.00 -15,817.20 0.00 0.00 0.00 -1.44
EBIT Less CapEx to Interest Expense		 0.00 0.00 -14,360.50 0.00 0.00 0.00 -55,692.00 0.00 0.00 0.00 -2.05
NOPAT Less CapEx to Interest Expense		 0.00 0.00 -10,717.50 0.00 0.00 0.00 -16,439.20 0.00 0.00 0.00 -1.53
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Precigen, Inc. (PGEN) has shown limited top-line growth in the latest quarters while continuing to burn cash and post losses. The company has taken steps to bolster liquidity through financing and asset sales, which is visible in select quarterly cash flows and balance-sheet changes. Below are the most relevant trends drawn from the last four years of quarterly statements.

  • In Q3 2025, Net Cash From Continuing Financing Activities was about $93.0 million, signaling a major financing event that boosted liquidity.
  • In Q4 2025, Net Cash From Investing Activities was about $39.9 million, driven by a large net inflow from the sale/maturity of investments (63.7 million) that outweighed purchases (23.9 million).
  • In Q2 2025, Net Cash From Investing Activities was about $28.4 million, reflecting ongoing asset sales/purchases that contributed to liquidity.
  • In Q4 2025, the company posted a net increase in cash and equivalents of about $15.9 million, indicating a sequential improvement in cash balance despite operating losses.
  • Total assets rose to roughly $171.3 million by Q3 2025, with total equity around $41.9 million, suggesting improved capitalization from financing activities.
  • Revenue remains modest and volatile, with quarterly operating revenue generally in the low single-digit millions (e.g., about $2.0–$2.9 million in 2025 quarters), lacking clear near-term top-line growth.
  • Retained earnings are deeply negative (for example, around -$2.32 billion in Q3 2025), indicating a large accumulated deficit despite recent equity improvements.
  • Earnings per share remain negative across recent quarters (e.g., Q4 2025 Basic EPS around -$0.04; Q3 2025 around -$1.06), reflecting ongoing losses per share.
  • Net income is negative across all recent quarters, with Q3 2025 showing a sizable pretax loss of about $146.3 million and Q4 2025 continuing operations at approximately -$25.7 million.
  • Operating cash flow is consistently negative in the latest quarters (e.g., Q4 2025: -$23.46 million; Q3 2025: -$29.07 million; Q2 2025: -$18.98 million; Q1 2025: -$16.33 million), indicating ongoing cash burn from core operations.
05/17/26 04:25 AM ETAI Generated. May Contain Errors.

Precigen Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Precigen's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Precigen's net income appears to be on a downward trend, with a most recent value of -$250.64 million in 2025, rising from -$85.62 million in 2014. The previous period was -$126.24 million in 2024. See Precigen's forecast for analyst expectations on what's next for the company.

Precigen's total operating income in 2025 was -$110.51 million, based on the following breakdown:
  • Total Gross Profit: $4.86 million
  • Total Operating Expenses: $115.37 million

Over the last 9 years, Precigen's total revenue changed from $71.93 million in 2014 to $9.68 million in 2025, a change of -86.5%.

Precigen's total liabilities were at $134.59 million at the end of 2025, a 71.4% increase from 2024, and a 51.4% decrease since 2015.

In the past 10 years, Precigen's cash and equivalents has ranged from $4.86 million in 2022 to $135.78 million in 2015, and is currently $30.23 million as of their latest financial filing in 2025.

Over the last 10 years, Precigen's book value per share changed from 5.96 in 2015 to 0.06 in 2025, a change of -99.0%.


Related Companies

Financial statements for NASDAQ:PGEN last updated on 5/14/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
Read this warning immediately
Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the bigg...
Porter & Company | Sponsoredtc pixel